Paroxetine (Aropax)
Paroxetine risk profile, scheduling, and guidance for claims professionals and care workers . Also known as Aropax, Paxtine, Paroxetine Sandoz, Extine 20, Paroxetine GH and 3 more.
Paroxetine (brand names: Aropax, Paxtine, Paroxetine Sandoz, Extine 20, Paroxetine GH and 3 more) is classified as Low risk (2 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. SSRI with moderate anticholinergic effects and higher discontinuation syndrome risk than other SSRIs.
Key Takeaways
- TGA Schedule: S4 in Australia
- Risk level: Low (2 points)
- Serotonergic: Risk of serotonin syndrome when combined with other serotonergic drugs
- PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | S4 | PBS listed |
Risk Profile
SSRI with moderate anticholinergic effects and higher discontinuation syndrome risk than other SSRIs.
Regulatory and Compliance Guidance
When Paroxetine appears on a claimant's medication list, claims professionals should assess whether the prescribing is appropriate for the compensable injury, whether the duration is within guidelines, and whether there are interactions with other medications on the claim.
Australia TGA / PBS / State Schemes
Classified as S4 under the Therapeutic Goods Administration (TGA).
Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.
United Kingdom NICE / MHRA / FPM
NICE guidelines recommend certain antidepressants (amitriptyline, duloxetine) for chronic pain management. For personal injury claims, antidepressant prescribing should be assessed for injury relatedness.
Need to assess this medication across your caseload?
Run a full risk assessment including Paroxetine interactions and compliance checks.
AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.
No credit card required. No signup for your first 2 questions.
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.